Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VTI1A anticorps (AA 1-175)

VTI1A Reactivité: Humain ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7175463
  • Antigène Voir toutes VTI1A Anticorps
    VTI1A (Vesicle Transport through Interaction with t-SNAREs 1A (VTI1A))
    Épitope
    • 9
    • 8
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-175
    Reactivité
    • 43
    • 26
    • 8
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 42
    • 2
    Lapin
    Clonalité
    • 42
    • 2
    Polyclonal
    Conjugué
    • 17
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp VTI1A est non-conjugé
    Application
    • 27
    • 19
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Vesicle transport through interaction with t-SNAREs homolog 1A protein (1-175AA)
    Isotype
    IgG
    Top Product
    Discover our top product VTI1A Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    VTI1A (Vesicle Transport through Interaction with t-SNAREs 1A (VTI1A))
    Autre désignation
    VTI1A (VTI1A Produits)
    Synonymes
    anticorps zgc:109895, anticorps mvti1, anticorps vti1-rp2, anticorps DDBDRAFT_0219803, anticorps DDBDRAFT_0231536, anticorps DDB_0219803, anticorps DDB_0231536, anticorps MMDS3, anticorps MVti1, anticorps VTI1RP2, anticorps Vti1-rp2, anticorps 1110014F16Rik, anticorps 1110018K19Rik, anticorps 4921537J05Rik, anticorps MVti1a, anticorps Vti1, anticorps vesicle transport through interaction with t-SNAREs 1A L homeolog, anticorps vesicle transport through interaction with t-SNAREs 1A, anticorps v-SNARE family protein, anticorps vti1a.L, anticorps vti1a, anticorps VTI1A, anticorps vti1A, anticorps Vti1a
    Sujet

    Background: V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. Involved in vesicular transport from the late endosomes to the trans-Golgi network. Along with VAMP7, involved in an non-conventional RAB1-dependent traffic route to the cell surface used by KCNIP1 and KCND2. May be involved in increased cytokine secretion associated with cellular senescence.

    Aliases: MMDS3 antibody, MVti1 antibody, SNARE Vti1a beta protein antibody, Vesicle transport through interaction with t-SNAREs homolog 1A antibody, Vesicle transport through interaction with tSNAREs homolog 1A (yeast) antibody, Vesicle transport v-SNARE protein Vti1-like 2 antibody, Vti1 rp2 antibody, Vti1-rp2 antibody, Vti1a antibody, VTI1A vesicle transport through interaction with t-SNAREs 1A antibody, VTI1A_HUMAN antibody, VTI1RP2 antibody

    UniProt
    Q96AJ9
Vous êtes ici:
Support technique